Showing results (1251-1260 of 1,566) with videos related to

Sort By:
Pageof 157
Pathophysiology : the Official Journal of the International Society for Pathophysiology|July 27, 2022
Oral Preparation of Hyaluronic Acid, Chondroitin Sulfate, Curcumin, and Quercetin (Ialuril® Soft Gels) for the Prevention of LUTS after Intravesical ChemotherapyCeleste Manfredi, Lorenzo Spirito, Francesco Paolo Calace, et al.
Communications Biology|July 19, 2022
A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infectionPasquale Laise, Megan L Stanifer, Gideon Bosker, et al.
Molecular Cancer Research : MCR|May 18, 2017
Epigenetic Regulation of ZBTB18 Promotes Glioblastoma ProgressionVita Fedele, Fangping Dai, Anie P Masilamani, et al.
Gut|January 20, 2019
Experimental microdissection enables functional harmonisation of pancreatic cancer subtypesCarlo Maurer, Sam R Holmstrom, Jing He, et al.
Breast Cancer Research and Treatment|June 25, 2021
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancerMatthew Kearney, Lauren Franks, Shing Lee, et al.
Research Square|February 8, 2022
A Model for Network-Based Identification and Pharmacological Targeting of Aberrant, Replication-Permissive Transcriptional Programs Induced by Viral InfectionPasquale Laise, Megan L Stanifer, Gideon Bosker, et al.
Biomedicines|October 26, 2024
Neoadjuvant Immunotherapy in Head and Neck Cancers: A Paradigm Shift in Treatment ApproachAlessia Zotta, Maria Luisa Marciano, Francesco Sabbatino, et al.
International Journal of Molecular Sciences|March 6, 2021
Hypogonadism in Patients with Prader Willi Syndrome: A Narrative ReviewLuigi Napolitano, Biagio Barone, Simone Morra, et al.
Genome Research|November 8, 2014
Cupid: simultaneous reconstruction of microRNA-target and ceRNA networksHua-Sheng Chiu, David Llobet-Navas, Xuerui Yang, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)C D'Alterio, G Rea, M Napolitano, et al.
Pageof 157